Top 5 Drug Type | Count |
---|---|
Small molecule drug | 1 |
Top 5 Target | Count |
---|---|
H3 receptor(Histamine H3 receptor) | 1 |
Target |
Mechanism H3 receptor agonists |
Active Org. |
Originator Org. |
Active Indication- |
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism A1R agonists |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication- |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism A1R agonists |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication- |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date11 Jul 2018 |
Sponsor / Collaborator |
Start Date01 Aug 2014 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Immethridine Dihydrobromide ( H3 receptor ) | - | Discovery |
LUF-5451 ( A2bR ) | Immune System Diseases More | Pending |
LUF 5853 ( A1R ) | - | Pending |
LUF 5834 ( A2bR ) | - | Pending |
VUF-5574 ( A3R ) | Asthma More | Pending |